Literature DB >> 6409920

Detection of Rift Valley fever virus antigen by enzyme-linked immunosorbent assay.

B Niklasson, M Grandien, C J Peters, T P Gargan.   

Abstract

A double-antibody (sandwich) enzyme-linked immunosorbent assay (ELISA) was adapted to detect Rift Valley fever virus antigen. Antibodies were purified from hyperimmune mouse and rabbit sera by affinity chromatography, using CNBr-activated Sepharose 4B coupled to a beta-propiolactone-inactivated sucrose-acetone-extracted suckling mouse liver antigen. In the assay, antigen was captured by mouse antibody adsorbed to polystyrene plates and then detected by reacting sequentially with rabbit anti-Rift Valley fever virus antibody and swine anti-rabbit immunoglobulin G conjugated to alkaline phosphatase. ELISA proved to be useful in measuring viral antigen in different animal systems. However, great variation was found in the amount of antigen per PFU encountered in different circumstances. The ELISA system was optimized using supernatant fluids from infected Vero cell cultures and had a sensitivity of 10(5) PFU/ml. Hamsters develop progressive viremia, much as seen in susceptible domestic animals, such as lambs; ELISA could reliably detect 10(6) PFU/ml of viremic hamster serum. Rhesus monkeys with Rift Valley fever infection were positive by ELISA even when viremias were only 5 X 10(3) PFU/ml. ELISA also proved to be useful in measuring viral antigen in infected mosquitoes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6409920      PMCID: PMC272795          DOI: 10.1128/jcm.17.6.1026-1031.1983

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

1.  The development of a formalin-killed Rift Valley fever virus vaccine for use in man.

Authors:  R RANDALL; C J GIBBS; C G AULISIO; L N BINN; V R HARRISON
Journal:  J Immunol       Date:  1962-11       Impact factor: 5.422

2.  An inactivated rift valley fever vaccine.

Authors:  B J Barnard; M J Botha
Journal:  J S Afr Vet Assoc       Date:  1977-03       Impact factor: 1.474

3.  Elimination of inter-species reactive anti-IgG antibodies by affinity chromatography.

Authors:  M E Johansson; J A Espmark
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

4.  Epidemic Rift Valley fever in Egypt: observations of the spectrum of human illness.

Authors:  L W Laughlin; J M Meegan; L J Strausbaugh; D M Morens; R H Watten
Journal:  Trans R Soc Trop Med Hyg       Date:  1979       Impact factor: 2.184

5.  Rift Valley fever affecting humans in South Africa: a clinicopathological study.

Authors:  D J van Velden; J D Meyer; J Olivier; J H Gear; B McIntosh
Journal:  S Afr Med J       Date:  1977-06-11

6.  The detection of viruses by enzyme-linked immunosorbent assay (ELISA).

Authors:  A Voller; A Bartlett; D E Bidwell; M F Clark; A N Adams
Journal:  J Gen Virol       Date:  1976-10       Impact factor: 3.891

7.  Detection of La Crosse arbovirus antigen in mosquito pools: application of chromogenic and fluorogenic enzyme immunoassay systems.

Authors:  S W Hildreth; B J Beaty; J M Meegan; C L Frazier; R E Shope
Journal:  J Clin Microbiol       Date:  1982-05       Impact factor: 5.948

8.  Fatal Rift Valley fever of man in Rhodesia.

Authors:  R Swanepoel; B Manning; J A Watt
Journal:  Cent Afr J Med       Date:  1979-01

9.  The Rift Valley fever epizootic in Egypt 1977-78. 1. Description of the epizzotic and virological studies.

Authors:  J M Meegan
Journal:  Trans R Soc Trop Med Hyg       Date:  1979       Impact factor: 2.184

  9 in total
  14 in total

1.  Rift Valley fever virus structural and nonstructural proteins: recombinant protein expression and immunoreactivity against antisera from sheep.

Authors:  Bonto Faburay; William Wilson; D Scott McVey; Barbara S Drolet; Hana Weingartl; Daniel Madden; Alan Young; Wenjun Ma; Juergen A Richt
Journal:  Vector Borne Zoonotic Dis       Date:  2013-08-20       Impact factor: 2.133

2.  Comparison of techniques for demonstrating antibodies to Rift Valley fever virus.

Authors:  R Swanepoel; J K Struthers; M J Erasmus; S P Shepherd; G M McGillivray; B J Erasmus; B J Barnard
Journal:  J Hyg (Lond)       Date:  1986-10

3.  Cross-sectional survey of Rift Valley fever virus exposure in Bodhei village located in a transitional coastal forest habitat in Lamu county, Kenya.

Authors:  Samuel Muiruri; Ephantus W Kabiru; Eric M Muchiri; Hassan Hussein; Frederick Kagondu; A Desirée LaBeaud; Charles H King
Journal:  Am J Trop Med Hyg       Date:  2014-12-22       Impact factor: 2.345

4.  Detection of Lassa virus antigens and Lassa virus-specific immunoglobulins G and M by enzyme-linked immunosorbent assay.

Authors:  B S Niklasson; P B Jahrling; C J Peters
Journal:  J Clin Microbiol       Date:  1984-08       Impact factor: 5.948

5.  Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention.

Authors:  Michel Pepin; Michele Bouloy; Brian H Bird; Alan Kemp; Janusz Paweska
Journal:  Vet Res       Date:  2010 Nov-Dec       Impact factor: 3.683

6.  Detection of human immunoglobulins G and M antibodies to Rift Valley fever virus by enzyme-linked immunosorbent assay.

Authors:  B Niklasson; C J Peters; M Grandien; O Wood
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

7.  Spectrum of Rift Valley fever virus transmission in Kenya: insights from three distinct regions.

Authors:  A Desiree LaBeaud; Yoshitsugu Ochiai; C J Peters; Eric M Muchiri; Charles H King
Journal:  Am J Trop Med Hyg       Date:  2007-05       Impact factor: 2.345

8.  Sensitive enzyme immunoassay for detecting immunoglobulin M antibodies to Sindbis virus and further evidence that Pogosta disease is caused by a western equine encephalitis complex virus.

Authors:  C H Calisher; O Meurman; M Brummer-Korvenkontio; P E Halonen; D J Muth
Journal:  J Clin Microbiol       Date:  1985-10       Impact factor: 5.948

9.  Evaluation of enzyme-linked immunosorbent assay and reversed passive hemagglutination for detection of Crimean-Congo hemorrhagic fever virus antigen.

Authors:  A J Shepherd; R Swanepoel; D E Gill
Journal:  J Clin Microbiol       Date:  1988-02       Impact factor: 5.948

10.  Interepidemic Rift Valley fever virus seropositivity, northeastern Kenya.

Authors:  A Desiree LaBeaud; Eric M Muchiri; Malik Ndzovu; Mariam T Mwanje; Samuel Muiruri; Clarence J Peters; Charles H King
Journal:  Emerg Infect Dis       Date:  2008-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.